PL360052A1 - Composition and method for stable injectable liquids - Google Patents

Composition and method for stable injectable liquids

Info

Publication number
PL360052A1
PL360052A1 PL00360052A PL36005200A PL360052A1 PL 360052 A1 PL360052 A1 PL 360052A1 PL 00360052 A PL00360052 A PL 00360052A PL 36005200 A PL36005200 A PL 36005200A PL 360052 A1 PL360052 A1 PL 360052A1
Authority
PL
Poland
Prior art keywords
composition
injectable liquids
stable injectable
stable
liquids
Prior art date
Application number
PL00360052A
Other languages
English (en)
Polish (pl)
Inventor
Bruce Joseph Roser
De Castro Arcadio Garcia
James Maki
Original Assignee
Cambridge Biostability Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biostability Ltd. filed Critical Cambridge Biostability Ltd.
Publication of PL360052A1 publication Critical patent/PL360052A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL00360052A 2000-10-13 2000-10-13 Composition and method for stable injectable liquids PL360052A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028244 WO2002032402A1 (fr) 2000-10-13 2000-10-13 Composition et procede pour liquides injectables stables

Publications (1)

Publication Number Publication Date
PL360052A1 true PL360052A1 (en) 2004-09-06

Family

ID=21741883

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00360052A PL360052A1 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Country Status (12)

Country Link
EP (1) EP1328255A1 (fr)
JP (1) JP2004513093A (fr)
KR (1) KR20030096224A (fr)
CN (1) CN100339066C (fr)
AU (2) AU2001211986B2 (fr)
CA (2) CA2424656C (fr)
ES (1) ES2337252T3 (fr)
MX (1) MXPA03003236A (fr)
NO (1) NO20031706D0 (fr)
PL (1) PL360052A1 (fr)
PT (1) PT1452171E (fr)
WO (1) WO2002032402A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502825A1 (fr) * 2002-10-22 2004-05-06 Dainippon Pharmaceutical Co., Ltd. Composition stabilisee
JP2007001865A (ja) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd 脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
JP2007532619A (ja) 2004-04-13 2007-11-15 ケンブリッジ バイオスタビリティ リミテッド 懸濁したガラス粒子を含有する液体
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8946200B2 (en) 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
MX2010007632A (es) * 2008-01-18 2010-08-03 Asahi Kasei Pharma Corp Composicion farmaceutica estable.
US8404850B2 (en) 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8722706B2 (en) 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
WO2010146536A1 (fr) 2009-06-18 2010-12-23 Koninklijke Philips Electronics N.V. Suspension de particules comprenant un médicament
WO2011007327A2 (fr) 2009-07-16 2011-01-20 Koninklijke Philips Electronics N.V. Suspension pour usage thérapeutique et dispositif d'administration de ladite suspension
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US9028873B2 (en) 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
EP3124275A4 (fr) 2014-03-24 2018-03-14 Seiko Epson Corporation Dispositif d'impression de bande et systeme d'impression de bande
CN106102724A (zh) * 2014-03-27 2016-11-09 诺华股份有限公司 用于吸入活性药物成分的经喷雾干燥的水包油包固体分散系

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78151B (fr) * 1982-04-05 1984-09-26 Alcon Lab Inc
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
AU3924193A (en) * 1992-03-19 1993-10-21 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids

Also Published As

Publication number Publication date
PT1452171E (pt) 2010-03-08
EP1328255A1 (fr) 2003-07-23
CN1527699A (zh) 2004-09-08
NO20031706L (no) 2003-04-11
AU1198601A (en) 2002-04-29
CA2424656A1 (fr) 2002-04-25
NO20031706D0 (no) 2003-04-11
CA2689856C (fr) 2013-09-24
WO2002032402A1 (fr) 2002-04-25
ES2337252T3 (es) 2010-04-22
MXPA03003236A (es) 2004-12-03
CA2424656C (fr) 2010-03-23
KR20030096224A (ko) 2003-12-24
JP2004513093A (ja) 2004-04-30
CN100339066C (zh) 2007-09-26
AU2001211986B2 (en) 2007-04-26
CA2689856A1 (fr) 2002-04-25

Similar Documents

Publication Publication Date Title
AU5752601A (en) Splice-region antisense composition and method
AU6275601A (en) Stable polymeric micelle-type drug composition and method for the preparation thereof
AU6832101A (en) Composition and method
GB0008264D0 (en) Novel method and compounds
AU4163402A (en) Composition and method
AU1198601A (en) Composition and method for stable injectable liquids
HUP0203746A3 (en) Novel composition and method for stabilizing the same
HK1039883A1 (zh) 用於穩定花色素原的組合物和方法
GB0126990D0 (en) Method and composition for improving fuel consumption
AU6866701A (en) New pet food composition and method
GB2372300B (en) Arrangement and method for avoiding overturning
AU2001251083A1 (en) Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
EP1351647A4 (fr) Compositions et methodes pour traiter l'hyperpigmentation
AU7311501A (en) Cosmetic composition and method
AU4215901A (en) Methods and compositions for immunoregulation
AU2001233932A1 (en) Method and composition
IL153487A0 (en) Pharmaceutical compositions and methods for use
EP1451068A4 (fr) Recipient pourvu de cannelures et procede d'utilisation
IL153897A0 (en) Pharmaceutical compositions and methods for use
IL145220A0 (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AU2002239775A1 (en) Chemical-library composition and method
AU7220501A (en) Mortar composition and method
AU2001288107A1 (en) Liquid deodorant composition and method for use thereof
EP1272512A4 (fr) Composition d'immunokine et methode associee
SG88779A1 (en) Food modification method and composition therefor

Legal Events

Date Code Title Description
DISD Decisions on discontinuance of the proceedings of a derived patent or utility model

Ref document number: 376992

Country of ref document: PL